Publication | Open Access
Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution
17
Citations
12
References
2020
Year
The incidence of EIR-AE in our study is similar to other series. Patients who develop EIR-AE might have a better prognosis compared to those who do not experience them.
| Year | Citations | |
|---|---|---|
Page 1
Page 1